✦ LIBER ✦

De Quervain’s Thyroiditis Associated with Interferon-α-2b Therapy for Non-Hodgkin’s Lymphoma

✍ Scribed by Dr A. Fortis, C. Christopoulos, E. Chrysadakou, E. Anevlavis

Book ID: 119929385
Publisher: Springer International Publishing AG
Year: 1998
Tongue: English
Weight: 221 KB
Volume: 16
Category: Article
ISSN: 1179-1918
DOI: 10.2165/00044011-199816060-00007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-α-2b beneficial in patients w

Interferon-α-2b beneficial in patients with hepatitis C and non-Hodgkin's lymphoma

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Pregnancy-associated α2-glycoprotein in

Pregnancy-associated α2-glycoprotein in children with acute lymphocytic leukemia, Hodgkin's disease and non-Hodgkin's lymphomas

✍ Fabián E. Zalazar; Gustavo A. Chiabrando; Nélida A. de Aldao; Félix Ojeda; Migue 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Combined Therapy with Rituximab Plus Cyc

Combined Therapy with Rituximab Plus Cyclophosphamide/Vincristine/Prednisone for Sjogren’s Syndrome-Associated B-Cell Non-Hodgkin’s Lymphoma

✍ J. Carbone; R. Perez-Fernandez; A. Muñoz; P. Sabin; L. Carreño; E. Fernandez-Cru 📂 Article 📅 2007 🏛 Humana Press Inc 🌐 English ⚖ 101 KB

Combination therapy with rituximab and i

Combination therapy with rituximab and interferon (IFN)-α-2a is `active, safe, and well tolerated' in patients with non-Hodgkin's lymphoma

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Combination trial of subcutaneous recomb

Combination trial of subcutaneous recombinant α2b interferon and oral cyclophosphamide in follicular low-grade non-Hodgkin's lymphoma

✍ Ozer, Howard ;Anderson, James R. ;Peterson, Bruce A. ;Budman, Daniel R. ;Cooper, 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 750 KB

## Abstract The follicular non‐Hodgkin's lymphomas (NHL) have been among those tumors demonstrated to show frequent responses to alpha interferon in phase I and II clinical trials. In addition, there are data suggesting that alpha interferon demonstrates synergistic antitumor activity with alkylati

Increased survival associated with radio

Increased survival associated with radiolabeled lym-1 therapy for non-hodgkin's lymphoma and chronic lymphocytic leukemia

✍ Gerald L. DeNardo; Kathleen R. Lamborn; Desirée S. Goldstein; Linda A. Kroger; S 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

on baseline Karnofsky performance status (KPS) and serum lactic dehydrogenase California. (LDH) predicted response and survival and was used to define risk groups. Propor-2 Brain Tumor Research Center, Department of tional-hazards, Kaplan-Meier, and Landmark models were used to evaluate pa-Neurolog